AI assistant
CVS HEALTH Corp — Director's Dealing 2021
Dec 28, 2021
29875_dirs_2021-12-28_6cec1c98-a8dc-420d-a978-fd70344cf145.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-12-27
Reporting Person: Lotvin Alan (EVP&President-PharmacyServices)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-27 | Common Stock (restricted) | F | 200 | $88.78 | Disposed | 5827 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 61341.3689 | Direct |
| Common Stock | 492 | Indirect |
| Stock Unit | 29851.1611 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Phantom Stock Credits | $1.00 | Common Stock (556.7643) | 556.7643 | Direct | |
| Stock Option | $102.26 | 2022-04-01 | Common Stock (21386) | 21386 | Direct |
| Stock Option | $104.82 | 2023-04-01 | Common Stock (27395) | 27395 | Direct |
| Stock Option | $78.05 | 2024-04-03 | Common Stock (32911) | 32911 | Direct |
| Stock Option | $62.21 | 2025-04-01 | Common Stock (22541) | 22541 | Direct |
| Stock Option | $54.19 | 2029-04-01 | Common Stock (70702) | 70702 | Direct |
| Stock Option | $58.34 | 2030-04-01 | Common Stock (140797) | 140797 | Direct |
| Stock Option | $74.30 | 2031-04-01 | Common Stock (120940) | 120940 | Direct |
Footnotes
F1: Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible.
F2: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F3: Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
F4: Option became exercisable in four equal annual installments, commencing 4/1/2016.
F5: Option became exercisable in four equal annual installments, commencing 4/1/2017.
F6: Option became exercisable in four equal annual installments, commencing 4/3/2018.
F7: Option became exercisable in four equal annual installments, commencing 4/1/2019.
F8: Option became exercisable in four equal annual installments, commencing 4/1/2020.
F9: The number of shares subject to the option were calculated using a 30-day average price.
F10: Option became exercisable in four equal annual installments, commencing 4/1/2021.
F11: Option becomes exercisable in four equal annual installments, commencing 4/1/2022.